We are well known in the market for offering Filgotinib CAS 1206161-97-8, also known as GLPG0634. Filgotinib (GLPG0634) CAS NO 1206161-97-8 is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively. In cell lines, GLPG0634 shows higher selectivity for JAK/STAT signaling involving JAK1 than JAK2 kinase in a cellular context. Processed Filgotinib (GLPG0634) 1206161-97-8 use superior quality raw material and in a clean and sterile condition. We promise the Filgotinib (GLPG0634) Cas 1206161-97-8 is high specification and high purity.

Thera. Category: JAK Inhibitor

Cas No.: 1206161-97-8

Synonym: GPLG0634;GLPG0634;SYN1158;CyclopropanecarboxaMide, N-[5-[4-[(1,1-dioxido-4-thioMorpholinyl)Methyl]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]-;GLPG0634 (analog);N-[5-[4-[(1,1-Dioxido-4-thiomorpholinyl)methyl]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide;Filgotinib (GLPG0634);N-[5-[4-[(1,1-Dioxido-4-thiomorpholinyl)methyl]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide Filgotinib (GLPG0634)

Molecular Formula: C21H23N5O3S

Molecular Weight:425.51

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage: Filgotinib (GLPG0634) is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively. Phase 2.

Related Product:
CAS 1206161-97-8, Filgotinib (GLPG0634)
CAS 59801-62-6, THIOMORPHOLINE 1,1-DIOXIDE HYDROCHLORIDE
CAS 1142943-96-1, Cyclopropanecarboxylic acid (5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)-amide